20-F/A: Prenetics Global Amends Annual Report to Include Key Subsidiary Financials

Prenetics Global Limited filed an amendment to its 2024 annual report to incorporate the separate financial statements of its significant equity method investment, Insighta Holdings Limited, as mandated by SEC regulations.

Summary

• The filing is Amendment No. 1 to Prenetics Global Limited's Annual Report on Form 20-F for the fiscal year ended December 31, 2024.
• The amendment's sole purpose is to comply with SEC Regulation S-X, Rule 3-09, by including separate financial statements for Insighta Holdings Limited, which was determined to be a significant equity method investment.
• Insighta Holdings Limited reported a profit before tax of HK$4,472,893 for the year ended December 31, 2024, a significant improvement from a loss of HK$2,060,756 for the period from July 20, 2023, to December 31, 2023.
• Insighta's revenue for the year ended December 31, 2024, was HK$244,218, up from HK$60,903 for the period from July 20, 2023, to December 31, 2023.
• As of December 31, 2024, Insighta's total assets were HK$637,432,339, with total equity amounting to HK$623,966,840.
• Insighta's cash and cash equivalents decreased from HK$617,047,711 at December 31, 2023, to HK$382,110,455 at December 31, 2024.
• Insighta acquired subsidiaries on November 16, 2023, with nil consideration, aiming to enhance and strengthen business development.

Sentiment

Score: 7

Explanation: The document primarily serves a compliance purpose by adding financial statements for a significant equity method investment. The included financials for Insighta Holdings Limited show a positive shift from a loss to a profit and increased revenue, which is favorable. However, the decrease in cash and cash equivalents for Insighta and the pro forma increase in loss from its own acquisition of subsidiaries temper the overall positive sentiment. The document does not provide strategic updates or overall company performance for Prenetics, limiting a broader sentiment assessment.

Positives

• Insighta Holdings Limited transitioned from a loss before tax of HK$2,060,756 in the prior period (July 20, 2023 December 31, 2023) to a profit before tax of HK$4,472,893 for the year ended December 31, 2024.
• Insighta's revenue increased from HK$60,903 in the prior period to HK$244,218 for the year ended December 31, 2024.
• Insighta's bank interest income significantly increased to HK$31,280,591 for the year ended December 31, 2024, from HK$12,382,698 in the prior period, indicating effective cash management or higher interest rates on substantial cash holdings.
• The acquisition of subsidiaries by Insighta on November 16, 2023, was stated to enhance and strengthen business development.

Negatives

• Insighta's cash and cash equivalents decreased significantly from HK$617,047,711 at December 31, 2023, to HK$382,110,455 at December 31, 2024.
• Pro forma information indicates that if Insighta's acquisition of subsidiaries had occurred earlier (July 20, 2023), consolidated loss would have increased by HK$8,911,574, suggesting the acquired entities were loss-making or had significant initial costs.

Risks

• Currency risk: The Group is exposed to foreign currency risk from bank balances mainly denominated in US$ and RMB, although management considers it minimal as HK$ is pegged to US$.
• Credit risk: The Group's credit risk exposures are primarily attributable to deposits and other receivables, cash and cash equivalents, and bank deposits, with no collateral held.
• Liquidity risk: The Group monitors and maintains a level of cash and cash equivalents deemed adequate to finance operations and mitigate the effects of fluctuations in cash flows.

Future Outlook

The document does not provide explicit forward-looking statements or guidance for Prenetics Global Limited or Insighta Holdings Limited beyond the pro forma impact of an acquisition.

Management Comments

• This Amendment does not affect any other parts of, or exhibits to, the Original Filing, nor does it reflect events occurring after the date of the Original Filing.
• Management believes that there are no significant increase in credit risk of these amounts since initial recognition and the Group provided impairment based on 12m ECL. (Referring to deposits and other receivables)
• The directors of the Group believe that there is no significant increase in credit risk of the amounts since initial recognition and the Group provided impairment based on 12m ECL. (Referring to amounts due from related companies)
• As HK$ is pegged to US$, the management of the Group thus considers the Group's foreign currency exposure is not significant.

Industry Context

This filing is an amendment to include specific financial statements of an equity method investee (Insighta Holdings Limited) in the biotechnology research sector. It does not provide broader industry analysis or competitive landscape details for Prenetics Global Limited. The focus is on regulatory compliance for a significant investment.

Comparison to Industry Standards

• The document does not provide specific comparable companies, projects, or results to assess against global benchmarks. It focuses solely on the financial performance of Insighta Holdings Limited.

Related Party Transactions

• Sales of laboratory testing kit to a related party: HK$60,903 for the period July 20, 2023, to December 31, 2023 (nil for 2024).
• Consultancy and management service income from a related party: HK$468,000 for 2024 and HK$156,000 for the period July 20, 2023, to December 31, 2023.
• Sales and marketing service income from a related party: HK$238,328 for 2024 (nil for 2023).
• Insighta acquired subsidiaries from Take2 Holdings Limited (a related party) with nil consideration on November 16, 2023, which was considered an arm's length transaction.
• Amounts due from related companies: HK$138,171 as of December 31, 2024 (HK$224,630 as of December 31, 2023), unsecured, interest-free, and repayable on demand.
• Amount due to a related company: HK$9,159,071 as of December 31, 2024 (HK$7,668,097 as of December 31, 2023), non-trade in nature, unsecured, interest-free, and repayable on demand.

Stakeholder Impact

• Shareholders (Prenetics Global Limited): The inclusion of Insighta's financials provides greater transparency regarding a significant equity investment, which could aid investment decisions. Insighta's shift to profitability is a positive for the value of this investment.
• Employees (Insighta Holdings Limited): The company's continued operations and growth (as indicated by increased revenue and profit) suggest stability for employees.
• Customers: Continued provision of biotechnology research services and laboratory testing kits.

Next Steps

• Prenetics Global Limited will continue to file reports required by Section 13 or 15(d) of the Securities Exchange Act of 1934.
• The company will continue to submit Interactive Data Files electronically.
• The directors of Insighta Holdings Limited are in the process of assessing the detailed impact of IFRS 18 on the consolidated financial statements, which will be effective for annual periods beginning on or after January 1, 2027.

Key Dates

Recommendation

Keywords

Prenetics Global Limited, Insighta Holdings Limited, SEC Filing, Form 20-F/A, Annual Report Amendment, Financial Statements, Equity Method Investment, Biotechnology Research, Financial Reporting, Corporate Governance, Risk Management, Nasdaq